GvHD Hub
Learning Objectives

Learning objectives

Following this symposium, participants will be able to:

  • Recall the latest data and recommendations relating to ECP use in GvHD
  • Identify which patients will benefit from ECP
  • State factors that may warrant avoidance or deferral of ECP
  • State best-practice recommendations for conducting ECP, including treatment schedules, anticoagulation practice, and safety monitoring strategies
  • State when to use ECP in patients with GvHD
  • State when, why, and how to combine ECP with other therapies, such as immunosuppressive agents, for GvHD treatment

Registration form

Registration is free. Please complete the form and submit to register.

The GvHD Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy